Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2019 Feb 7;7(1):e000613.
doi: 10.1136/bmjdrc-2018-000613. eCollection 2019.

Selenium supplementation and insulin resistance in a randomized, clinical trial

Elizabeth Theresa Jacobs #  1   2   3 , Peter Lance #  2   4 , Lawrence J Mandarino  4   5 , Nathan A Ellis  2 , H-H Sherry Chow  2 , Janet Foote  1 , Jessica A Martinez  2   3 , Chiu-Hsieh Paul Hsu  1   2 , Ken Batai  6 , Kathylynn Saboda  2 , Patricia A Thompson  7
Affiliations
Randomized Controlled Trial

Selenium supplementation and insulin resistance in a randomized, clinical trial

Elizabeth Theresa Jacobs et al. BMJ Open Diabetes Res Care. .

Abstract

Objective: While controversial, observational and randomized clinical trial data implicate the micronutrient selenium (Se) in the development of type 2 diabetes (T2D). The aim of this study was to test the hypothesis that Se supplementation adversely affects pancreatic β-cell function and insulin sensitivity.

Research design and methods: In a subset of 400 individuals participating in a randomized, placebo-controlled trial of Se at 200 µg/day for colorectal adenomatous polyps, fasting plasma glucose and insulin were measured before randomization and within 6 months of completing intervention. Change in the homeostasis model assessment-β cell function (HOMA2-%β) and insulin sensitivity (HOMA2-%S) were compared between arms. A subgroup of 175 (79 Se and 96 placebo) participants underwent a modified oral glucose tolerance test (mOGTT) at the end of intervention and change in glucose values was assessed.

Results: No statistically significant differences were observed for changes in HOMA2-%β or HOMA2-%S between those who received Se compared with placebo. After a mean of 2.9 years on study, mean HOMA2-%β values were 3.1±24.0 and 3.1±29.8 for the Se and placebo groups, respectively (p=0.99). For HOMA2-%S, the values were -0.5±223.2 and 80.9±1530.9 for the Se and placebo groups, respectively (p=1.00). Stratification by sex or age did not reveal any statistically significant effects on insulin sensitivity by treatment group. For mOGTT, mean baseline fasting blood glucose concentrations were significantly higher among participants in the placebo group compared with the Se group (96.6±14.6 and 92.3±12.0, respectively; p=0.04), a trend which remained through the 20 min assessment.

Conclusions: These findings do not support a significant adverse effect of daily Se supplementation with 200 µg/day of selenized yeast on β-cell function or insulin sensitivity as an explanation for previously reported associations between Se and T2D. Further clarification of longer term effects of Se is needed.

Clinical trial registry: NIH Clinical Trials.gov number NCT00078897.

Keywords: HOMA; OGTT; homeostatic model assessment; insulin resistance; selenium; supplementation.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: None declared.

References

    1. Clark LC, Combs GF, Turnbull BW, et al. . Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional prevention of cancer Study Group. JAMA 1996;276:1957–63. - PubMed
    1. Lippman SM, Klein EA, Goodman PJ, et al. . Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009;301:39–51. - PMC - PubMed
    1. Thompson PA, Ashbeck EL, Roe DJ, et al. . Selenium supplementation for prevention of colorectal adenomas and risk of associated type 2 diabetes. J Natl Cancer Inst 2016;108. 10.1093/jnci/djw152 - DOI - PMC - PubMed
    1. Stranges S, Marshall JR, Natarajan R, et al. . Effects of long-term selenium supplementation on the incidence of type 2 diabetes. Ann Intern Med 2007;147:217–23. 10.7326/0003-4819-147-4-200708210-00175 - DOI - PubMed
    1. Zhang H, Yan C, Yang Z, et al. . Alterations of serum trace elements in patients with type 2 diabetes. J Trace Elem Med Biol 2017;40:91–6. 10.1016/j.jtemb.2016.12.017 - DOI - PubMed

Publication types

Associated data

LinkOut - more resources